Table 2. Events per 10,000 women during their reproductive lifetime and estimates for the entire female population in India.
| Strategies | Strategy A [National] | Strategy B [Rural] | Strategy C [Urban] | |||
|---|---|---|---|---|---|---|
| Access to CEmOC [%] | 50.2 | 47.2 | 55.7 | |||
| CS rate [%] | 17.2 | 12.8 | 28.2 | |||
| Differences between strategies | Strategy A [Baseline] | Change from Strategy A to B [B-A] | Change from Strategy A to C [C-A] | |||
| Per 10,000 women | Per total population | Per 10,000 women | Per total population | Per 10,000 women | Per total population | |
| Pregnancies to full term | 646 | 20,998,079 | +2.1 | +68,735 | -0.2 | -7,743 |
| Vaginal Deliveries | 522 | 16,957,079 | +47 | +1,539,119 | -84 | -2,732,176 |
| Cesarean Sections | 173 | 5,628,779 | -58 | -1,888,050 | +116 | +3,764,628 |
| Neonates that survive | 621 | 20,180,625 | -0.1 | -4,780 | +6.68 | +217,006 |
| Neonates that die | 10 | 334,498 | +2.2 | +71,934 | -6.9 | -224,572 |
| Maternal mortality | 0.5 | 15,296 | -0.12 | +875,673 | -18.7 | -6,692 |
| Maternal mortality per 100,000 live birth | 75 | -19 | 33 | |||
| Neonatal mortality per 1,000 live births | 16 | 3 | -11 | |||
| Complications associated with increased CS rates | ||||||
| Previa | 0.5 | 16,252 | -0.09 | -2,868 | +0.38 | +12,428 |
| Accreta | 0.4 | 13,384 | -0.06 | -1,912 | +0.38 | +12,428 |
| Hysterectomy | 0.3 | 10,516 | +8.97 | +291,572 | +0.24 | +7,648 |
| ICU admissions | 0.1 | 2,868 | -0.09 | -2,772 | +0.03 | +956 |
| Uterine Rupture | 0.4 | 117,585 | +3.73 | +15,296 | +3.4 | +4,780 |
| PPH requiring transfusion | 2.2 | 701,685 | +19.93 | +16,252 | +20 | +34,415 |
| Complications associated with lack of access to CEmOC care | ||||||
| Fistula | 0.003 | 956 | +0.03 | 0.0 | 0.0 | -860 |
| Incontinence | 0.009 | 2,868 | +0.08 | 0.0 | +0.1 | 0.0 |
| Stroke | 0.021 | 6,692 | +0.16 | -956 | +0.2 | 0.0 |
| Uterine Rupture | 0.4 | 117,585 | +3.73 | +15,296 | +3.4 | +4,780 |
| PPH requiring transfusion | 2.2 | 701,685 | +19.93 | +16,252 | +20 | +34,415 |
Mean number of complications per woman during her reproductive lifetime are presented as number of complications per 10,000 women and for the entire female population of reproductive age in India in 2018. Absolute numbers are presented for the baseline strategy [national average access to CEmOC and CS rate] and the difference between the baseline strategy and the rural and urban strategy are presented. A positive number represents an increase in the number of events while a negative value is a decrease in the number of events.